TP53 and colorectal adenocarcinoma: Overall survival of colorectal adenocarcinoma patients was correlated with high vs. low (>1 or <−1 standard deviation from the mean, respectively) basal expression of transcripts within pan-drug, drug-specific, drug class-specific, p53-independent, and p53-dependent signatures.